News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MacroPore Biosurgery, Inc. (MRPOF.PK) Announces Third Quarter 2004 Financial Results; Reports On Progress Of Regenerative Cell Technology Program


10/19/2005 5:12:13 PM

MacroPore Biosurgery, Inc. (Frankfurt:XMP), a company developing therapies for cardiovascular disease, spine and orthopedic disorders and reconstructive surgery using adult stem cells from adipose tissue, today announced financial results for the three and nine months ended September 30, 2004.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES